Companion Diagnostics Market Assessment: Key Players, Innovations, and Strategic Partnerships
The Companion Diagnostics Market is gaining traction in emerging economies due to rising healthcare infrastructure investments and growing awareness of personalized medicine. Countries in Asia-Pacific, Latin America, and the Middle East are beginning to adopt companion diagnostics for oncology and infectious diseases. While affordability remains a concern, local manufacturing and international collaborations are making tests more accessible. As healthcare systems in these regions modernize, the adoption of companion diagnostics is expected to accelerate significantly.
1 View